Condition: Ventilation Therapy · ALS · Chronic Respiratory Failure · Sponsor: Tampere University
This research will study whether noninvasive ventilation (NIV) used to treat chronic respiratory insufficiency in patients with amyotrophic lateral sclerosis (ALS) can be initiated as successfully in the outpatient setting as in the conventional inpatient setting, and what the costs of these alternative initiation methods are.
This description comes directly from the study's public registry record.
Heidi A Rantala, MD, PhD · +3583311611 · heidi.rantala@tuni.fi
Hanna Korkeamäki, MD, MSc · +3583311611 · hanna.korkeamaki@pirha.fi
Always discuss trial participation with your own doctor first.
| Tampere University Hospital | Tampere, Finland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06286917